Financials
- Market Capitalization 27.17 M
- Employee 29
- Founded 2017
- CEO N/A
- Website www.bioxceltherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00K20GVD2
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.28
ratio cours/chiffre d'affaires
30.42
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4504 | PSTV PLUS THERAPEUTICS, Inc. - Common Stock | 4.17 USD | +4.25% | +3.73% | -18.40% | +1163.64% | 28.70 M USD | ||
| 4505 | ATNM Actinium Pharmaceuticals, Inc. Common Stock | 0.91 USD | -3.19% | -5.21% | -10.78% | -12.50% | 28.55 M USD | ||
| 4522 | GRDX GridAI Technologies Corp. - Common Stock | 4.07 USD | -9.56% | -6.86% | -26.00% | +59.61% | 27.08 M USD | ||
| 4529 | IGC IGC Pharma, Inc. Common Stock | 0.26 USD | -3.70% | -7.14% | -7.14% | +1.48% | 26.02 M USD |